Health Condition 1: L811- Chloasma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Clinically diagnosed Melasma
Exclusion criteria
Exclusion criteria: Any one of the following- 1. Pregnant and/ or lactating women 2. Women taking oral contraceptives or hormonal replacement therapy 3. Patients taking oral or topical treatment for Melasma 4 weeks prior to the study 4. Any known systemic illness 5. Active skin disease present locally 6. History of Photosensitive disorder 7. Patients having keloidal tendency 8. Bleeding diathesis 9. Unwilling to participate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparing efficacy of both groups by the change in modified MASI score and Physician Global Assessment (PGA) score.Timepoint: At each follow up visit. Final assessment will be done 2 weeks after the last session. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To assess dermoscopic changes in both treatment groups. 2. To observe and assess side effects in both treatment groups 3. To evaluate patient satisfaction using a percentage-based scoring systemTimepoint: At each follow up visit. Final assessment will be done 2 weeks after the last session. | — |
Countries
India
Contacts
AIIMS Jodhpur